Invion Limited 7C8.F Stock
Invion Limited Price Chart
Invion Limited 7C8.F Financial and Trading Overview
| Invion Limited stock price | 0.0030 EUR |
| Previous Close | 0.002 EUR |
| Open | 0.001 EUR |
| Bid | 0.001 EUR x 210000000 |
| Ask | 0.0075 EUR x 19091000 |
| Day's Range | 0.001 - 0.001 EUR |
| 52 Week Range | 0.001 - 0.01 EUR |
| Volume | 40K EUR |
| Avg. Volume | 1.07K EUR |
| Market Cap | 12.09M EUR |
| Beta (5Y Monthly) | 1.239463 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
7C8.F Valuation Measures
| Enterprise Value | 4.81M EUR |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 3.0685055 |
| Price/Book (mrq) | 0.33333334 |
| Enterprise Value/Revenue | 1.22 |
| Enterprise Value/EBITDA | -3.332 |
Trading Information
Invion Limited Stock Price History
| Beta (5Y Monthly) | 1.239463 |
| 52-Week Change | -80.00000000000000000000000000000000% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.01 EUR |
| 52 Week Low | 0.001 EUR |
| 50-Day Moving Average | 0.0036 EUR |
| 200-Day Moving Average | 0.0035575 EUR |
7C8.F Share Statistics
| Avg. Volume (3 month) | 1.07K EUR |
| Avg. Daily Volume (10-Days) | 5.1K EUR |
| Shares Outstanding | 6.42B |
| Float | 3.62B |
| Short Ratio | N/A |
| % Held by Insiders | 47.04% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | June 30, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | June 30, 2023 |
Profitability
| Profit Margin | -51.42% |
| Operating Margin (ttm) | -51.44% |
| Gross Margin | 26.74% |
| EBITDA Margin | -36.62% |
Management Effectiveness
| Return on Assets (ttm) | -6.29% |
| Return on Equity (ttm) | -10.34% |
Income Statement
| Revenue (ttm) | 3.94M EUR |
| Revenue Per Share (ttm) | 0.001 EUR |
| Quarterly Revenue Growth (yoy) | 49.79% |
| Gross Profit (ttm) | 969.12K EUR |
| EBITDA | -1442561 EUR |
| Net Income Avi to Common (ttm) | -2025575 EUR |
| Diluted EPS (ttm) | 0 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 8.03M EUR |
| Total Cash Per Share (mrq) | 0.001 EUR |
| Total Debt (mrq) | 0 EUR |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 13.207 |
| Book Value Per Share (mrq) | 0.003 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -421989 EUR |
| Levered Free Cash Flow (ttm) | -4691680 EUR |
Profile of Invion Limited
| Country | Germany |
| State | VIC |
| City | Melbourne |
| Address | 100 Albert Road |
| ZIP | 3205 |
| Phone | 61 3 9692 7222 |
| Website | https://www.inviongroup.com |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Invion Limited, a clinical-stage life-sciences company, researches and develops photodynamic therapy for the treatment of various cancers in Australia. The company is developing IVX-PDT, a photosensitizer agent to treat skin cancers, as well as solid cancers, including lung, prostrate, ovarian, and mesothelioma cancers. It has a research and development agreement with Hudson Institute of Medical Research to collaborate on a range of research and development projects for the Photosoft technology for the treatment of a range of cancers; and research agreement with Peter MacCallum Cancer Centre to undertake pre-clinical and in-vitro studies on Invion's IVX-PDT Photodynamic therapy for ano-genital cancers, including penile and anal cancer. The company was incorporated in 2000 and is headquartered in Melbourne, Australia.
Q&A For Invion Limited Stock
What is a current 7C8.F stock price?
Invion Limited 7C8.F stock price today per share is 0.0030 EUR.
How to purchase Invion Limited stock?
You can buy 7C8.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Invion Limited?
The stock symbol or ticker of Invion Limited is 7C8.F.
Which industry does the Invion Limited company belong to?
The Invion Limited industry is Drug Manufacturers-Specialty & Generic.
How many shares does Invion Limited have in circulation?
The max supply of Invion Limited shares is 6.6B.
What is Invion Limited Price to Earnings Ratio (PE Ratio)?
Invion Limited PE Ratio is now.
What was Invion Limited earnings per share over the trailing 12 months (TTM)?
Invion Limited EPS is 0 EUR over the trailing 12 months.
Which sector does the Invion Limited company belong to?
The Invion Limited sector is Healthcare.